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CASE REPORT
Bisphosphonate-related atypical insufficiency fracture  
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Abstract : Objective : Only a few cases of insufficiency fractures of the tibial plateau following bisphosphonate 
use have been reported. The authors report a case with bisphosphonate (BP) -related atypical insufficiency 
fracture of tibial plateau, which developed delayed union. Patient : A 65-year-old Japanese woman presented 
with left knee pain without any trauma. She had a 5-year history of risedronate use for primary osteoporosis. 
Initial X-rays were unremarkable, but magnetic resonance imaging (MRI) confirmed an insufficiency fracture 
at the left tibial plateau at 3 weeks after the initial visit. Risedronate treatment was stopped because we diag-
nosed her with a BP-related atypical insufficiency fracture of the tibial plateau. She was treated with rest, a 
lateral wedge insole and protective weight-bearing with a T-cane for 3 months. Result : At 3-month follow-up, 
the patient still had a pain and a delayed healing on radiographs. Six months later, X-rays showed that the 
fracture site had a sclerotic change, but MRI revealed delayed union. At 8-month follow-up, the fracture was 
healed without any symptoms. Conclusion : All clinicians need to be aware of the delayed healing of atypical 
insufficiency fracture related with prolonged BP use. J. Med. Invest. 68 : 186-188, February, 2021
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INTRODUCTION
 
Osteoporosis is characterized by lower bone mass and deteri-
oration of the microarchitecture of bone tissue, leading to bone 
fragility and a consequent increase in fracture risk (1). An asso-
ciation between long-term use of the anti-bone resorptive agent 
bisphosphonate (BP) and atypical subtrochanteric or diaphyseal 
insufficiency fractures of the femur has been well documented 
(2, 3). BP-related atypical insufficiency fractures usually have a 
delayed healing.  Here, we report a case with a delayed healing 
of insufficiency tibial plateau fracture associated with 5-year 
risedronate use. The patient gave consent for data concerning 
this case to be submitted for publication.
CASE PRESENTATION
A 65-year-old Japanese female presented with a sudden onset 
of pain in the left knee without any trauma. Her knee pain wors-
ened on standing from sitting and walking. The patient visited 
our clinic the day after onset. Her body weight, height and body 
mass index was 47.5 kg, 150.5 cm and 20.8, respectively. She had 
no history of metabolic disease except primary osteoporosis. She 
had been treated with oral weekly risedronate (17.5 mg) for five 
years for osteoporosis. Dual-energy X-ray absorptiometry (DXA) 
was performed at lumbar vertebrae before BP treatment was 
started and again at three and five years after initiating treat-
ment. T scores at the lumber vertebrae (L2-4) improved from -4.0 
at the beginning of treatment to -3.4 at three years and -2.9 at 
five years after treatment. Physical examination revealed mild 
tenderness over the medial proximal tibia. Range of motion of 
the left knee was limited from 0° extension to 100° flexion. Ante-
ro-posterior radiographs of the left knee demonstrated an almost 
normal appearance (Fig. 1A). She was prescribed analgesics 
(celecoxib 200 mg / day) and a lateral wedge insole for the medial 
knee pain. However, two weeks after the initial visit the pain 
worsened and she had difficulty walking. Magnetic resonance 
imaging (MRI) was performed a week later and demonstrated 
extra-articular, proximal metaphyseal linear signal changes on 
T1- and T2- weighted images and surrounding marrow edema 
and reactive changes on short-tau inversion recovery (STIR) im-
ages (Figs. 2A and 2B). Blood tests performed at the initial visit 
with knee pain revealed a β-CTx concentration of 0.195 pg / L 
and total P1NP of 32.5 µg / L, suggesting low bone turnover. 
Finally, the patient was diagnosed with a BP-related atypical 
insufficiency fracture of the tibial plateau. Risedronate treat-
ment was stopped after this diagnosis, and the patient started on 
daily vitamin K 45 mg and injection of elcatonin 10mg biweekly 
for 3 months, followed by eldecalcitol 0.75 μg daily. In addition, 
rest, lateral wedge insole and protective weight-bearing with 
a T-cane, were continued for 3 months. One month after the 
initial visit, her left knee had a pain and mild swelling. X-rays 
demonstrated a sclerotic change over the proximal medial me-
taphyseal region of the tibia, as well as a breach in continuity 
of the lateral cortex of proximal tibia with no comminution and 
minimal overlap (Fig. 1B). At 3 months follow-up, knee pain was 
decreased but tenderness was over the lateral tibial plateau. 
She could walk without any support. X-rays demonstrated dis-
continuity of the lateral cortex, indicating delayed healing (Fig. 
1C). At 6 months follow-up, the patient complaint a slight medial 
knee pain. Follow-up radiographs performed after six months 
showed healing of the fracture with sclerotic changes extending 
throughout the metaphyseal region from medial to lateral cortex 
(Fig. 1D), but MRI still revealed fracture lines and surrounding 
edema (Figs. 2C and 2D). At 8 months follow-up, radiographs 
demonstrated bone healing, and the patient had no pain or lim-
itation in activities of daily living. 
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DISCUSSION
Recently, several case series reported an association between 
long-term BP therapy and atypical proximal metaphyseal and 
diaphyseal femoral insufficiency fractures (2, 3). However, 
atypical fracture of the tibial plateau associated with long-term 
BP use is uncommon, with most cases reported to date being 
fractures of the tibial diaphysis (4, 5). Imbuldeniya reported on a 
Caucasian woman with bilateral atypical insufficiency fractures 
of the tibial plateau and a unilateral distal femoral fracture 
associated with long-term BP therapy (oral alendronate for 3 
years and intravenous pamidronate for the following 6 years) 
(6). Although they did not mention delayed healing, they showed 
patient’s symptoms lasting more than 6 months and image ab-
normalities for more than one year, suggesting a delayed union 
as same as in our case. 
The first report of atypical femoral fractures (AFFs) was 
published in 2005 and described 9 cases of non-spinal fractures 
(7). BPs, a class of antiresorptive agents, are an analogue of 
naturally occurring pyrophosphates. These nitrogen-containing 
compounds reduce the rate of bone resorption, increase bone 
mineral density, and improve trabecular connectivity by binding 
to bone surface. The resultant effect is improved bone strength 
and reduced risk of fracture (8). However, concerns have been 
raised over the past decade regarding the potential to over sup-
press bone turnover with long-term BP use, leading to atypical 
skeletal fragility (7, 9). Prolonged BP use has been suggested 
to cause accumulation of microdamage in bone, reduced het-
erogeneity of the organic matrix and mineral properties (10), 
increased levels of advanced glycation end products (11), and 
thereby promoting the deterioration of bone quality. Thus, AFFs 
have been considered as stress fractures caused by the suppres-
sion of remodeling, resulting from long term BP treatment (3).
Stress fractures of the medial tibial plateau are well known 
to be caused by repetitive mechanical stress in runners and in 
military personnel (12, 13). Other factors such as surgery for 
anterior cruciate ligament reconstruction (14) and unicompart-
mental knee arthroplasty (15, 16), drug-induced osteoporosis 
(17, 18), and even primary and postpartum osteoporosis without 
BP use (19, 20) can also cause these fractures. Generally, medial 
tibial plateau stress fractures can be managed conservatively 
simply by the cessation of sports activity, and symptoms usually 
resolve within two months (12, 13, 21). We treated this patient 
with a lateral wedge insole and protective weight-bearing with 
a T-cane, but this case had a concomitant lateral tibial plateau 
fracture, and further resulted in a delayed healing. In previous 
case report, they have prescribed knee supports even though 
it has been seven months after the initial symptoms. In such 
a BP-related atypical insufficiency fracture, early short-term 
casting and / or knee supporter might be considered to prevent 
delayed union and deformity of the fracture site. In addition, 
MRI-STIR images are the most useful investigative tool when 
the index of suspicion is high (21, 22). Since X-ray changes are 
quite subtle during the period of prodromal pain, we recommend 
using MRI to investigate patients treated long-term with BP.
In conclusion, the involvement of a non-femoral fracture site 
also suggests high risk for other weight-bearing bones following 
long-term BP therapy. Insufficiency fractures of the tibial pla-
teau can occur in osteoporosis alone, but if it occurs during BP 
therapy, the risk of delayed union should be considered.
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Figure 1.　Serial antero-posterior plain radiographs of the left knee at the initial visit (A), 1 month (B), 3 months (C), 
6 months (D), and 8 months (E) after the initial visit.
Figure 2.　T1 and short-tau inversion recovery (STIR)-weighted 
MRI coronal views of the left knee at 3 weeks (A and B) and 6 
months (C and D) after the initial visit.
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